Phase 3 Open-label Extension Trial With Rotigotine in Idiopathic Restless Legs Syndrome Subjects

Clinical trial NCT00498108 · COMPLETED

Trial details

NCT number: NCT00498108
Sponsor: UCB Pharma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Idiopathic Restless Legs Syndrome

Start date: 2006-01-01
Primary completion: 2007-09-01
Enrollment: 341

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.